Lax S, Fritz W, Browning K, Ravel J
Proc Natl Acad Sci U S A. 1985 Jan;82(2):330-3. doi: 10.1073/pnas.82.2.330.
Three highly purified preparations (preparations I, II-1, and II-2) have been obtained from wheat germ and shown to support in vitro polypeptide synthesis directed by capped or uncapped mRNAs in a eukaryotic initiation factor 4B (eIF-4B)-deficient system. The three preparations differ, however, in polypeptide composition and in the ability to overcome the inhibitory effect of 7-methylguanosine 5'-triphosphate (m7GTP) on in vitro polypeptide synthesis. Preparation I contains two polypeptides (Mr = 80,000 and 28,000), which are present in a 1:1 molar ratio and are associated in a high molecular weight complex. Preparation II-1 contains two major polypeptides (Mr = 220,000 and 26,000) and preparation II-2 also contains two major polypeptides (Mr = 110,000 and 26,000). Preparations II-1 and II-2 are high molecular weight complexes; neither contains detectable amounts of a Mr 80,000 or a Mr 50,000 component. Preparations II-1 and II-2 both overcome m7GTP inhibition, whereas preparation I does not. These findings raise several questions with regard to the identity of eIF-4B and its relationship to cap recognition factors.
已从小麦胚芽中获得了三种高度纯化的制剂(制剂I、II-1和II-2),并证明它们能在真核起始因子4B(eIF-4B)缺陷系统中支持由加帽或未加帽mRNA指导的体外多肽合成。然而,这三种制剂在多肽组成以及克服7-甲基鸟苷5'-三磷酸(m7GTP)对体外多肽合成抑制作用的能力方面存在差异。制剂I含有两种多肽(分子量分别为80,000和28,000),它们以1:1的摩尔比存在,并结合形成高分子量复合物。制剂II-1含有两种主要多肽(分子量分别为220,000和26,000),制剂II-2也含有两种主要多肽(分子量分别为110,000和26,000)。制剂II-1和II-2是高分子量复合物;两者均未检测到分子量为80,000或50,000的成分。制剂II-1和II-2都能克服m7GTP的抑制作用,而制剂I则不能。这些发现引发了关于eIF-4B的身份及其与帽识别因子关系的几个问题。